Jane Urheim | Stern Investor Relations |
Derek Chalmers | President & Chief Executive Officer |
Mani Mohindru | Chief Financial Officer & Chief Strategy Officer |
Jason Gerberry | Bank of America |
David Amsellem | Piper Jaffray |
Nick Rubino | Stifel |
Charles Duncan | Cantor Fitzgerald |
Alan Carr | Needham & Company |
Esther Hong | Janney |
Good afternoon and welcome to Cara Therapeutics Second Quarter and 2019 Financial Results Conference Call. All participants are now in listen-only mode. There will be a question-and-answer session at the end. Please be advised that this call is being recorded at Cara's request.
I would now like to turn the call over to Cara team.